Soley Therapeutics Funding, Investors & Competitors

Soley Therapeutics has raised $220M across 2 funding rounds, most recently a $200M Series C in January 2026.

Last Soley Therapeutics funding round

$200M

Series C · Jan 2026

Cumulative funding Soley Therapeutics raised

$220M

across 2 funding rounds

Key investors in Soley Therapeutics

  • Breyer Capital
  • Surveyor Capital
  • GordonMD Global Investments
  • Doug Leone Family Fund
  • HRTG Partners
  • RWN Management

Soley Therapeutics Overview

About Soley Therapeutics

Soley Therapeutics develops drugs using AI-analyzed high-content phenotypic screening of cellular responses via microscopy images. Headquartered in Vienna, Austria, the platform identifies novel therapies for oncology and immunology. The company collaborates with pharma partners on phenotypic assays measuring multi-dimensional drug effects. Founded in 2020, Soley Therapeutics raised seed funding and published findings in Nature Methods.


Founded

2018

HQ

United StatesSan Francisco, CA

Status

Privately held

Customer focus

B2B

Revenue model

Licensing, Subscription

Soley Therapeutics Funding History

Soley Therapeutics has raised a total of $220M across 2 funding rounds.

Soley Therapeutics' first fundraising round was a $20M undisclosed-stage round in December 2020. The most recent completed round was a $200M Series C in January 2026.

Soley Therapeutics funding rounds

Soley Therapeutics funding rounds
DateStageInvestorsRaisedDeal Summary
Jan 2026Series CSurveyor Capital (lead); Breyer Capital; GordonMD Global Investments; RWN Management; HRTG Partners; Doug Leone Family Fund$200MSoley Therapeutics announced a $200 million Series C financing on January 7, 2026, to advance its proprietary cell stress sensing platform and pipeline of novel therapeutics into the clinic. The company is a science-first, tech-enabled drug discovery and development firm based in South San Francisco that leverages artificial intelligence and computer vision to analyze thousands of responses in human cells to help design new therapeutic molecules. Surveyor Capital (a Citadel Company) served as the primary investor, joined by new backers HRTG Partners and RWN Management, along with returning existing investors including Doug Leone Family Fund, Breyer Capital, and GordonMD Global Investments. The Series C proceeds will support IND-enabling work and clinical trials for two first-in-class internally discovered and developed oncology assets, with the lead asset for acute myeloid leukemia (AML) on track for IND filing in 2026 and a second asset for solid tumors entering IND-enabling studies. The funding will also advance non-oncology stress-reducing drug candidates for neurodegenerative disorders and metabolic diseases, and continue platform scale-up. The company's cell stress sensing technology measures how living human cells respond to drug exposure and translates this cellular information into a robust portfolio of novel drug candidates across disease areas.
Dec 2020Undisclosed stage-$20M-

Who has invested in Soley Therapeutics?

6 investors have backed Soley Therapeutics across its funding rounds, including Breyer Capital, Surveyor Capital, GordonMD Global Investments, Doug Leone Family Fund, HRTG Partners and RWN Management.

Lead investors include Surveyor Capital.


Soley Therapeutics Investors

Investors in Soley Therapeutics by funding rounds participated
InvestorHQRoundsRoleFirst check
Breyer CapitalUnited StatesSan Francisco, CA1ParticipantJan 2026
GordonMD Global InvestmentsUnited StatesLos Angeles, CA1ParticipantJan 2026
RWN ManagementUnited StatesUnited States1ParticipantJan 2026
HRTG PartnersUnited StatesUnited States1ParticipantJan 2026

This data is available for Pro users. Sign up to see all 6 Soley Therapeutics investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Soley Therapeutics Competitors

Soley Therapeutics competitors include listed companies like SAP and Snowflake, and private ones like Astromech, Chai Discovery, Anthropic and OpenAI.

Public and private companies comparable to Soley Therapeutics
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
AstromechUnited StatesUnited StatesPrivate--$3.8B-
Chai DiscoveryUnited StatesSan Francisco, CAPrivate$48M-$3.8B-
AnthropicUnited StatesSan Francisco, CAPrivate$47B-$965B20.5x
OpenAIUnited StatesSan Francisco, CAPrivate$25B-$852B34.1x
SAPGermanyGermanyPublicly listed$42B$13B$248B5.4x
SnowflakeUnited StatesUnited StatesPublicly listed$4.7B($1.3B)$119B21.0x

Soley Therapeutics Public Comps

Soley Therapeutics is still privately-owned, but its public comps include Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche, Novartis, AstraZeneca, CrowdStrike, SAP and Amgen.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Eli Lilly$65B$28B16.5x13.1x38.7x27.0x
Johnson & Johnson$94B$40B7.2x6.8x17.0x18.3x
AbbVie$61B$17B8.7x8.1x30.6x17.6x
Merck$65B$28B6.3x6.2x14.7x21.0x
Roche$77B$26B5.0x4.9x14.6x12.4x
Novartis$57B$22B5.5x5.5x14.2x13.3x
AstraZeneca$59B$19B4.8x4.5x14.6x12.7x
CrowdStrike$4.8B($12M)51.4x44.5x(19816.2x)151.0x

This data is available for Pro users. Sign up to see all Soley Therapeutics competitors and their valuation data.

Start Free Trial

Common questions about Soley Therapeutics

When was Soley Therapeutics founded?Soley Therapeutics was founded in 2018.
Where is Soley Therapeutics headquartered?Soley Therapeutics is headquartered in San Francisco, CA, United States.
Is Soley Therapeutics publicly listed?No, Soley Therapeutics is a private, VC-backed company.
How much funding has Soley Therapeutics raised?Soley Therapeutics has raised $220M across 2 funding rounds.
What was Soley Therapeutics' last funding round?Soley Therapeutics' last funding round was a $200M Series C in January 2026, led by Surveyor Capital.
Who are Soley Therapeutics' investors?Soley Therapeutics' investors include Breyer Capital, GordonMD Global Investments, RWN Management, HRTG Partners, Surveyor Capital and Doug Leone Family Fund.
Which companies are comparable to Soley Therapeutics?Companies comparable to Soley Therapeutics include Astromech, Chai Discovery, Anthropic, OpenAI, SAP and Snowflake.

See companies similar to Soley Therapeutics

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial